A CLIA waived drug test with fentanyl is not simply a drug test that happens to detect fentanyl. It is a fundamentally different category of screening device: one that carries the Clinical Laboratory Improvement Amendments waiver that permits results to be used for clinical decision-making in healthcare settings, alongside FDA approval that confirms the device meets federal regulatory standards for accuracy and reliability. The CLIA waived fentanyl drug test range at Surge includes integrated urine cups, multi-panel dip cards, single-panel fentanyl strips, and the FentaScan fluorescence analyzer system, all certified CLIA Waived and FDA Approved, and all including fentanyl detection as a dedicated panel. The most clinically significant feature across every product in this category is the Fentanyl (FEN) cutoff of 1 ng/mL, the most sensitive fentanyl detection threshold available in a rapid point-of-care device. Standard Forensic Use Only screening devices typically detect fentanyl at 10 to 20 ng/mL. At 1 ng/mL, these CLIA waived devices detect fentanyl at concentrations that are clinically relevant for pain management compliance monitoring, addiction treatment, and any setting where confirming the presence or absence of fentanyl at therapeutic or sub-therapeutic levels is a clinical requirement.
Every product in this category is CLIA Waived, FDA Approved, and detects Fentanyl as a dedicated panel. The combination of clinical certification and ultra-sensitive fentanyl detection at 1 ng/mL makes this the category for pain clinics, addiction treatment programs, clinical laboratories, and healthcare providers that need results they can act on, not just screen with. Substances covered across the product range include:
Fentanyl and Synthetic Opioid Detection
Fentanyl (FEN) at 1 ng/mL across all multi-panel products, Norfentanyl (NFYL) at 5 ng/mL in the 15 panel cup, FentaScan fluorescence detection at 1 ng/mL with 100% specificity
Opioids and Opioid Maintenance Substances
Opiates / Morphine (OPI/MOR), Oxycodone (OXY), Methadone (MTD), Buprenorphine (BUP), EDDP (methadone metabolite, 14 panel cup only)
Stimulants and Illicit Drugs
Amphetamines (AMP), Methamphetamine (MET), Cocaine (COC), MDMA / Ecstasy (MDMA)
Prescription Sedatives and CNS Depressants
Benzodiazepines (BZO), Barbiturates (BAR), Phencyclidine (PCP), Tricyclic Antidepressants (TCA), Tramadol (TML), Propoxyphene (PPX)
Cannabis Detection
Marijuana / THC (THC) at 50 ng/mL across all multi-panel products
